Similar articles

• Ras farnesyltransferase: a new therapeutic target.

  Leonard DM. Leonard DM. J Med Chem. 1997 Sep 12;40(19):2971-90. doi: 10.1021/jm970226l. J Med Chem. 1997. PMID: 9301658 Review. No abstract available.
• Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.

  Qian Y, Vogt A, Sebti SM, Hamilton AD. Qian Y, et al. J Med Chem. 1996 Jan 5;39(1):217-23. doi: 10.1021/jm950414g. J Med Chem. 1996. PMID: 8568811
• Ras C-terminal processing enzymes--new drug targets?

  Gibbs JB. Gibbs JB. Cell. 1991 Apr 5;65(1):1-4. doi: 10.1016/0092-8674(91)90352-y. Cell. 1991. PMID: 2013090 Review. No abstract available.
• Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.

  Leftheris K, Kline T, Vite GD, Cho YH, Bhide RS, Patel DV, Patel MM, Schmidt RJ, Weller HN, Andahazy ML, Carboni JM, Gullo-Brown JL, Lee FY, Ricca C, Rose WC, Yan N, Barbacid M, Hunt JT, Meyers CA, Seizinger BR, Zahler R, Manne V. Leftheris K, et al. J Med Chem. 1996 Jan 5;39(1):224-36. doi: 10.1021/jm950642a. J Med Chem. 1996. PMID: 8568812
• Farnesyl-derived inhibitors of ras farnesyl transferase.

  Kang MS, Stemerick DM, Zwolshen JH, Harry BS, Sunkara PS, Harrison BL. Kang MS, et al. Biochem Biophys Res Commun. 1995 Dec 5;217(1):245-9. doi: 10.1006/bbrc.1995.2770. Biochem Biophys Res Commun. 1995. PMID: 8526918